Epidemiology, variable genetic organisation and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients.
Standard
Epidemiology, variable genetic organisation and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients. / Franke, Gefion; Böckenholt, Alexandra; Sugai, Motoyuki; Rohde, Holger; Aepfelbacher, Martin.
in: MICROBIOL-SGM, Jahrgang 156, 2010, S. 860-872.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Epidemiology, variable genetic organisation and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients.
AU - Franke, Gefion
AU - Böckenholt, Alexandra
AU - Sugai, Motoyuki
AU - Rohde, Holger
AU - Aepfelbacher, Martin
PY - 2010
Y1 - 2010
N2 - EDIN-B (Epidermal cell Differentiation INhibitor-B; also termed C3Stau) is an exotoxin of S. aureus which ADP-ribosylates and inactivates Rho GTP-binding proteins. The EDIN-B gene (edin-B) and the gene for exfoliative toxin D (etd) make up the central part of a recently described pathogenicity island. Here we evaluated the prevalence and genetic organisation of the edin-B/etd pathogenicity island in invasive S. aureus isolates and characterized edin-B transcription and EDIN-B production using artificial constructs transduced in S. aureus strains RN6390 and -Newman. We found that 8 out of 121 (7 %) S. aureus blood culture isolates harbour edin-B which is organised in three novel variants of the original edin-B/etd pathogenicity island. In the serum of patients infected with edin-B positive S. aureus significant titres of anti-EDIN-B antibodies could be detected. Regulation of edin-B transcription depended on the sarA- but not on the agr regulatory system. Furthermore, retrieval of EDIN-B protein secreted by S. aureus RN6390 required the presence of alpha2-macrogobulin to inhibit the activity of extracellular proteases. These data suggest that the EDIN-B toxin is produced during human infection, is part of a highly variable pathogenicity island and can be controlled by the sarA gene regulon and secreted bacterial proteases.
AB - EDIN-B (Epidermal cell Differentiation INhibitor-B; also termed C3Stau) is an exotoxin of S. aureus which ADP-ribosylates and inactivates Rho GTP-binding proteins. The EDIN-B gene (edin-B) and the gene for exfoliative toxin D (etd) make up the central part of a recently described pathogenicity island. Here we evaluated the prevalence and genetic organisation of the edin-B/etd pathogenicity island in invasive S. aureus isolates and characterized edin-B transcription and EDIN-B production using artificial constructs transduced in S. aureus strains RN6390 and -Newman. We found that 8 out of 121 (7 %) S. aureus blood culture isolates harbour edin-B which is organised in three novel variants of the original edin-B/etd pathogenicity island. In the serum of patients infected with edin-B positive S. aureus significant titres of anti-EDIN-B antibodies could be detected. Regulation of edin-B transcription depended on the sarA- but not on the agr regulatory system. Furthermore, retrieval of EDIN-B protein secreted by S. aureus RN6390 required the presence of alpha2-macrogobulin to inhibit the activity of extracellular proteases. These data suggest that the EDIN-B toxin is produced during human infection, is part of a highly variable pathogenicity island and can be controlled by the sarA gene regulon and secreted bacterial proteases.
M3 - SCORING: Zeitschriftenaufsatz
VL - 156
SP - 860
EP - 872
JO - MICROBIOL-SGM
JF - MICROBIOL-SGM
SN - 1350-0872
ER -
